Compare ARQT & COLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARQT | COLM |
|---|---|---|
| Founded | 2016 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.2B |
| IPO Year | 2020 | 1997 |
| Metric | ARQT | COLM |
|---|---|---|
| Price | $27.74 | $62.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $34.00 | ★ $62.50 |
| AVG Volume (30 Days) | ★ 1.9M | 512.3K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.00% |
| EPS Growth | ★ 88.79 | N/A |
| EPS | N/A | ★ 0.65 |
| Revenue | $376,072,000.00 | ★ $3,042,478,000.00 |
| Revenue This Year | $34.85 | $3.73 |
| Revenue Next Year | $29.39 | $3.29 |
| P/E Ratio | ★ N/A | $97.86 |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $13.70 | $47.48 |
| 52 Week High | $31.77 | $69.06 |
| Indicator | ARQT | COLM |
|---|---|---|
| Relative Strength Index (RSI) | 62.27 | 48.82 |
| Support Level | $22.09 | $53.13 |
| Resistance Level | $28.80 | $64.87 |
| Average True Range (ATR) | 1.24 | 1.98 |
| MACD | 0.07 | -0.18 |
| Stochastic Oscillator | 51.09 | 45.41 |
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. It sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.